IDH2 and cancer: Just as the discovery of IDH mutation sparked great interest in cancer metabolism in the neuro-oncology field, we have the opportunity to take it to the next step using metabolomics to help understand disease progression and changes in cancer profiles across all cancer types (Crooks et al., 2021; Kwon et al., 2015).